Outstanding Core Facility Support - COVID-19 Resilience Award, Vice Chancellor Research Administration
(2021)
Recognition for "ongoing efforts and diligence during the pandemic", and "dedication to CU and the research mission".
Publications
Carrel A, Napoli E, Hixson K, Carlsen J, Cruz Del Angel Y, Strode D, Busquet N, Kumar V, Wempe MF, Russek SJ, Brooks-Kayal AR. Ruxolitinib-dependent reduction of seizure load and duration is accompanied by spatial memory improvement in the rat pilocarpine model of temporal lobe epilepsy. Neurotherapeutics. 2024 Dec 5;:e00506. [Epub ahead of print] PubMed PMID: 39643584
Swanson MA, Jiang H, Busquet N, Carlsen J, Brindley C, Benke TA, Van Hove RA, Friederich MW, MacLean KN, Mesches MH, Van Hove JLK. Deep postnatal phenotyping of a new mouse model of nonketotic hyperglycinemia. J Inherit Metab Dis. 2024 Sep;47(5):971-990. PubMed PMID: 38840294
Anton PE, Rutt LN, Kaufman ML, Busquet N, Kovacs EJ, McCullough RL. Binge ethanol exposure in advanced age elevates neuroinflammation and early indicators of neurodegeneration and cognitive impairment in female mice. Brain Behav Immun. 2024 Feb;116:303-316. PubMed PMID: 38151165
Anton PE, Rutt LN, Kaufman ML, Busquet N, Kovacs EJ, McCullough RL. Corrigendum to "Binge ethanol exposure in advanced age elevates neuroinflammation and early indicators of neurodegeneration and cognitive impairment in female mice" [Brain Behav. Immun. 116 (2024) 303-316]. Brain Behav Immun. 2024 Aug;120:644-645. PubMed PMID: 38702200
Anton PE, Nagpal P, Moreno J, Burchill MA, Chatterjee A, Busquet N, Mesches M, Kovacs EJ, McCullough RL. NF-?B/NLRP3 Translational Inhibition by Nanoligomer Therapy Mitigates Ethanol and Advanced Age-Related Neuroinflammation. bioRxiv. 2024 Feb 28. PubMed PMID: 38464118